New Treatments for Malignant Gliomas: Careful Evaluation and Cautious Optimism Required

@article{Gilbert2006NewTF,
  title={New Treatments for Malignant Gliomas: Careful Evaluation and Cautious Optimism Required},
  author={M. Gilbert},
  journal={Annals of Internal Medicine},
  year={2006},
  volume={144},
  pages={371-373}
}
  • M. Gilbert
  • Published 2006
  • Medicine
  • Annals of Internal Medicine
The treatment of patients with glioblastoma is a showcase for improved technology in many disciplines of medicine. Imaging technology has improved substantially, leading to more accurate and rapid diagnosis; better anatomic localization, which leads to improvements in neurosurgical results; and earlier detection of recurrent or relapsing disease. Surgical techniques have improved with better tumor delineation, which results in a higher percentage of patients having what seems to be complete… Expand
Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings1
...
1
2
...

References

SHOWING 1-10 OF 16 REFERENCES
Neuro-oncology clinical trials: promise and pitfalls.
  • M. Gilbert
  • Medicine
  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2001
Adding Chloroquine to Conventional Treatment for Glioblastoma Multiforme
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.
Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma.
Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study.
...
1
2
...